Shield Blood Test
An FDA-approved blood test that screens for colorectal-cancer-associated alterations in cell-free DNA for average-risk adults age 45 and older.
Review status. This record is live for catalog testing, but its Test Grade and dimension scores are still awaiting editorial publication.
colorectal-cancer-screening
The official patient information documents intended use, eligible population, blood collection, result meaning, FDA status, and required follow-up after a positive result.
A positive result requires colonoscopy, and Shield is not a replacement for diagnostic or surveillance colonoscopy in high-risk individuals.